<DOC>
	<DOCNO>NCT02532543</DOCNO>
	<brief_summary>This study intend provide statistically robust evidence Symbios Demineralized Cortical-cancellous granule mix , Symbios OsteoGraf LD-300 , OsteoGraf/N-300 combine Symbios OsteoShield Collagen Resorbable Membrane adequately support alveolus ridge augmentation procedure , reduce dimensional change alveolus overlie soft tissue . Additionally , comparison material make , provide evidence material ' ability preserve alveolus . It intend define objective term response hard soft tissue ridge augmentation .</brief_summary>
	<brief_title>Comparative Volumetric Assessment Alveolar Ridge Preservation Utilizing Different Bone Grafting Materials</brief_title>
	<detailed_description />
	<mesh_term>Tooth Diseases</mesh_term>
	<mesh_term>Tooth Injuries</mesh_term>
	<mesh_term>Tooth Fractures</mesh_term>
	<criteria>1 . Provision inform consent 2 . ≥ 18 year ≤ 75 year 3 . Good physical health ( ASAI/II ) 4 . Extraction maxillary premolar , canine incisor , mandibular premolar canine require 5 . Teeth adjacent ( mesial distal ) study site must consist two stable natural teeth minimal restoration , without sign periodontal bone loss ( &gt; 3 mm ) and/or significant soft tissue deficiencies 1 . Buccal plate dehiscence and/or fenestration &gt; 3mm study site follow extraction 2 . Untreated rampant caries uncontrolled periodontal disease 3 . Inadequate oral hygiene ( estimate plaque score &gt; 20 % ) 4 . Smokers use 10 cigarette equivalent per day 5 . Smokeless tobacco use ecigarette use 6 . Compromised physical health and/or uncontrolled severe systemic disease include : ASA III/IV Metabolic bone disease History malignancy History radiotherapy chemotherapy malignancy past 5 year History autoimmune disease Longterm steroidal antibiotic therapy Uncontrolled diabetes Known alcohol drug abuse 7 . Systemic local disease condition would compromise postoperative heal 8 . Use substance medication influence bone metabolism 9 . Known pregnancy 10 . Unable unwilling return followup visit period 6 month 11 . Unlikely able comply study procedure accord Investigators judgement 12 . Involvement plan conduct study 13 . Previous enrollment randomization treatment present study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>